UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy

Journal of experimental & clinical cancer research, 2024-03, Vol.43 (1), p.66-66, Article 66

2024

Volltextzugriff (PDF)

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma leukemia effects and safety

Leukemia, 2010-06, Vol.24 (6), p.1160-1170

2010

Volltextzugriff (PDF)

Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

Leukemia, 2020-04, Vol.34 (4), p.1102-1115

2020

Volltextzugriff (PDF)

Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult philadelphia-positive acute lymphoblastic leukemia

Leukemia, 2005-04, Vol.19 (4), p.628-635

2005

Volltextzugriff (PDF)

443 T-cell repertoire in metastatic melanoma patients developing skin leukoderma after treatment with checkpoint inhibitors

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S257-S257

2022

Volltextzugriff (PDF)

High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia

Hepatology (Baltimore, Md.), 1996-06, Vol.23 (6), p.1377-1383

1996

Volltextzugriff (PDF)

850 - Process Development and Manufacturing: OUTCOMES OF THE T2EVOLVE EUROPEAN SURVEY ON CAR T CELL ANALYTICAL METHODS FROM APHERESIS TO POST-INFUSION IMMUNOMONITORING

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S188-S189

2023

Volltextzugriff (PDF)

Process Development and Manufacturing: OUTCOMES OF THE T2EVOLVE EUROPEAN SURVEY ON CAR T CELL ANALYTICAL METHODS FROM APHERESIS TO POST-INFUSION IMMUNOMONITORING

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S188-S189

2023

Volltextzugriff (PDF)

T2EVOLVE: STANDARDIZATION OF PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ENGINEERED T CELL THERAPY IN EUROPE; A CROSS FUNCTIONAL MULTI STAKEHOLDER INITIATIVE

Cytotherapy (Oxford, England), 2024-06, Vol.26 (6), p.S117-S118

2024

Volltextzugriff (PDF)

BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations

Oncogene, 2002-12, Vol.21 (56), p.8652-8667

2002

Volltextzugriff (PDF)

Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole

British journal of pharmacology, 1996-12, Vol.119 (7), p.1438-1446

1996

Volltextzugriff (PDF)

S1635 ACADEMIC, PHASE1 TRIAL ON T CELLS EXPRESSING BOTH CD19 CHIMERIC ANTIGEN RECEPTOR AND INDUCIBLE CASPASE 9 SAFETY SWITCH FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA AND NON‐HODGKIN LYMPHOMA

HemaSphere, 2019-06, Vol.3 (S1), p.755-n/a

2019

Volltextzugriff (PDF)

LUPUS Anticoagulant and Increased Thrombin Generation in Patients with Systemic Lupus Erythematosus

Blood, 1994-01, Vol.83 (1), p.304-304

1994

Volltextzugriff (PDF)

Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis

BMJ, 1990-04, Vol.300 (6732), p.1099-1102

1990

Volltextzugriff (PDF)

Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations

Haematologica (Roma), 2003-11, Vol.88 (11), p.1296

2003

Volltextzugriff (PDF)

Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis

Gastroenterology (New York, N.Y. 1943), 1995-08, Vol.109 (2), p.531-539

1995

Volltextzugriff (PDF)

Antiphospholipid antibodies, hypercoagulability and thrombosis

Haematologica (Roma), 1995-03, Vol.80 (2 Suppl), p.131

1995

Volltextzugriff (PDF)

High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia

Hepatology (Baltimore, Md.), 1996-06, Vol.23 (6), p.1377-1383

1996

Volltextzugriff (PDF)

Engineering CD19-Redirected T Lymphocytes to Enhance Their Safety and Efficacy

Biology of blood and marrow transplantation, 2009-02, Vol.15 (2), p.1-1

2009

Volltextzugriff (PDF)

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo

Blood, 2006-11, Vol.108 (11), p.1721-1721

2006

Volltextzugriff (PDF)

Preferentially Expressed Antigen of Melanoma (PRAME)-Specific Cytotoxic T-Lymphocytes (CTLs) and Transgenic T Cells To Target Chronic Myelogenous Leukemia (CML)

Blood, 2007-11, Vol.110 (11), p.2761-2761

2007

Volltextzugriff (PDF)

Gene Transfer of IL-7R alpha (IL-7Rα) on Antigen-Specific Cytotoxic T Cells (CTLs) Restores Their Ability To Respond to IL-7 Cytokine

Blood, 2007-11, Vol.110 (11), p.2756-2756

2007

Volltextzugriff (PDF)

Generation Of Virus-Specific Cytotoxic T Lymphocytes (CTLS) Resistant to the Immunosuppressive Drug Tacrolimus (FK506)

Biology of blood and marrow transplantation, 2009-02, Vol.15 (2), p.135-135

2009

Volltextzugriff (PDF)

Genetic Modification of Antigen-Specific Cytotoxic T Lymphocytes (CTLS) Restores Their Ability to Respond to Interleukin-7 (IL-7)

Biology of blood and marrow transplantation, 2009-02, Vol.15 (2), p.23-23

2009

Volltextzugriff (PDF)

Polyclonal Prame-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid Leukemia

Biology of blood and marrow transplantation, 2009-02, Vol.15 (2), p.58-59

2009

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(52)
Humans
(46)
Female
(25)
Male
(25)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Adult
(22)
Middle Aged
(22)
Hematology
(16)
Aged
(15)
Animals
(12)
Gastroenterology. Liver. Pancreas. Abdomen
(12)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(11)
Other Diseases. Semiology
(11)
Gastroenterology & Hepatology
(10)
Liver Cirrhosis - Blood
(10)
Cardiovascular System & Cardiology
(9)
Cell Biology
(8)
Peripheral Vascular Disease
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Histochemie
(9)
Blood
(8)
Histochemistry And Cell Biology
(8)
Thrombosis Research
(7)
Hepatology
(6)
Fibrinolysis
(5)
Thrombosis And Haemostasis
(5)
Biology Of Blood And Marrow Transplantation
(4)
Bmj. British Medical Journal
(4)
Europace
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma leukemia effects and safety

Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult philadelphia-positive acute lymphoblastic leukemia

443 T-cell repertoire in metastatic melanoma patients developing skin leukoderma after treatment with checkpoint inhibitors

High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia

850 - Process Development and Manufacturing: OUTCOMES OF THE T2EVOLVE EUROPEAN SURVEY ON CAR T CELL ANALYTICAL METHODS FROM APHERESIS TO POST-INFUSION IMMUNOMONITORING

Process Development and Manufacturing: OUTCOMES OF THE T2EVOLVE EUROPEAN SURVEY ON CAR T CELL ANALYTICAL METHODS FROM APHERESIS TO POST-INFUSION IMMUNOMONITORING

T2EVOLVE: STANDARDIZATION OF PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ENGINEERED T CELL THERAPY IN EUROPE; A CROSS FUNCTIONAL MULTI STAKEHOLDER INITIATIVE

BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations

Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole

S1635 ACADEMIC, PHASE1 TRIAL ON T CELLS EXPRESSING BOTH CD19 CHIMERIC ANTIGEN RECEPTOR AND INDUCIBLE CASPASE 9 SAFETY SWITCH FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA AND NON‐HODGKIN LYMPHOMA

LUPUS Anticoagulant and Increased Thrombin Generation in Patients with Systemic Lupus Erythematosus

Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis

Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations

Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis

Antiphospholipid antibodies, hypercoagulability and thrombosis

High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia

Engineering CD19-Redirected T Lymphocytes to Enhance Their Safety and Efficacy

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo

Preferentially Expressed Antigen of Melanoma (PRAME)-Specific Cytotoxic T-Lymphocytes (CTLs) and Transgenic T Cells To Target Chronic Myelogenous Leukemia (CML)

Gene Transfer of IL-7R alpha (IL-7Rα) on Antigen-Specific Cytotoxic T Cells (CTLs) Restores Their Ability To Respond to IL-7 Cytokine

Generation Of Virus-Specific Cytotoxic T Lymphocytes (CTLS) Resistant to the Immunosuppressive Drug Tacrolimus (FK506)

Genetic Modification of Antigen-Specific Cytotoxic T Lymphocytes (CTLS) Restores Their Ability to Respond to Interleukin-7 (IL-7)

Polyclonal Prame-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid Leukemia

Suchergebnisse filtern